Fig. 1From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trialBlood count differences between the two groups. CCRT: concurrent chemoradiotherapy; WBC: white blood cell; ANC: absolute neutrophil count; RBC: red blood cell; PLT: platelet; HB: hemoglobin. * Factors with statistical significance: ns: no significance; *: p < 0.05; **: p < 0.01; ***: p < 0.001Back to article page